| --- | --- | --- | --- | |----------------------------------|----------|-------|-------| | | | | | | | | | | | | | | | | Investor Presentation March 2020 | | | | | oncolyticsbiotech.com | TSX ONC | | | Forward-Looking Statements This presentation contains certain forward-looking statements relating to the company's business prospects and the development and commercialization of pelareorep, a first-in-class systemically administered immuno-oncology agent for solid tumors and heme malignancies. These stateme ...